Fig. 6
From: Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance
Clinical significance of mRNAsi and determination of stemness-related genes. A mRNAsi differences in normal vs tumor group at various clinical stages. B Kaplan-Meier survival analysis of COADs with mRNAsi groups. C mRNAsi differences in chemosensitive vs chemoresistant groups. D Tumorigenesis, stemness, clinical stage, and chemoresistance related differential gene expression are presented as a Venn plot. E mRNAsi differences among metastases. F Heatmap of mRNAsi with chemoresistance, metastasis, and tumor stages